Anti-ageing is the most commercially valuable claim space in skincare and the one where the gap between the marketing copy and the regulatory position is widest. A serum that describes how skin looks after eight weeks of use is a well-behaved cosmetic. The same serum described as boosting collagen, repairing DNA or regenerating cells is making a biological claim that a cosmetic product in most markets is not entitled to make.
The formulation challenge is equally real. The three active families that dominate the category, retinoids, peptides and bakuchiol, each bring a different stability problem, a different irritation profile and a different packaging requirement, and they do not combine as freely as a marketing brief tends to assume.
This guide is written for brand owners and formulators developing an anti-ageing serum for private label or custom manufacturing. It covers what each active family actually does, how the delivery and packaging have to change around them, how the claims can be framed defensibly, and how to test for the evidence that supports them.
Ingredient restrictions in this category change more often than in most others, particularly for retinoids. Confirm the current permitted concentrations for each target market before the formula is frozen.
What anti-ageing formulation can and cannot do
A cosmetic can change the appearance of the skin surface. It can improve hydration, which immediately reduces the visibility of fine lines. It can support the surface barrier, which affects how smooth and even the skin looks. It can influence the appearance of tone and texture. And it can do this with enough measurable consistency that an instrumental study will show a difference.
What a cosmetic cannot do, in regulatory terms, is claim to change the structure or biology of the skin, to prevent or treat a condition, or to produce a physiological effect. That boundary rules out a large amount of the language that circulates in the category, including references to collagen production, cellular regeneration and DNA repair.
The practical test for a claim is whether it describes what the consumer sees or what the product does inside the body. Appearance language is generally available to a cosmetic with evidence. Mechanism language is where brands run into difficulty, and it is usually unnecessary: the consumer buys an anti-ageing serum for how their skin looks, not for a mechanism.
| Active family | Tolerance | Main stability challenge | Delivery and pack | Suits |
|---|---|---|---|---|
| Retinoids | Lowest; dryness and flaking during the adjustment period | Oxidation and light degradation in water containing formulas | Encapsulation plus airless, opaque packaging | The strongest performance positioning, with the highest claim exposure |
| Peptides | Good | Peptide specific pH windows and interactions with some preservatives | A standard emulsion or gel; encapsulation usually unnecessary | An easy to launch firming positioning with broad market acceptance |
| Bakuchiol | Good, and oil soluble | Requires an oil phase or an emulsion base | A standard pack, with amber glass where light sensitivity matters | A gentler alternative with a plant derived story and a smaller evidence base |
Retinoids: the strongest actives and the most regulated
Retinol and its esters remain the benchmark against which the rest of the category is judged, and they are also the family subject to the most active regulatory tightening. Several markets have moved to restrict retinoid concentrations, with limits that differ by product type and by application site, and with labelling requirements attached. Some restrict the levels permitted in body products to well below those used in facial products, which means a face and body range cannot simply use the same base.
Stability is the second problem. Retinol degrades through oxidation and through exposure to light, and it degrades faster in a water-containing formula than in an anhydrous one. Three practical measures follow. The formula should be protected with an antioxidant system and chelation, the process should minimise heat and oxygen exposure, and the packaging should exclude light and ideally air.
Irritation is the third problem, and it is what drives most of the returns in the category. Retinol produces dryness, flaking and redness during the adjustment period in a proportion of users, and the proportion rises with concentration. Encapsulation reduces the rate of release and therefore the irritation peak, and it also improves stability, which is why encapsulated retinol is common in premium products. The trade-off is cost and a slower onset of visible effect.
The formulation route that works best in practice is a moderate concentration with encapsulation, in a barrier-supportive base containing emollients and humectants rather than a stripped-back gel. A supporting base does more for the consumer experience than a higher active load.
Peptides: reliable, well tolerated and easy to over-claim
Peptides occupy a comfortable middle ground. They are generally well tolerated, they work across a broad pH range, and they are compatible with most preservative systems, which makes them the easiest anti-ageing active to build a formula around. They are also the family where the gap between the ingredient name and the evidence base is largest, because a great many peptides are marketed on in-vitro data and only a subset have human use data behind them.
Two technical points matter during development. Each peptide has its own pH stability window and some are sensitive to specific preservatives or to chelating agents, so the compatibility check has to happen before the preservative system is fixed. And peptides are typically used at low concentrations, which means the formula's sensorial character is defined by the base rather than by the active, so the base has to be designed for the positioning rather than treated as filler.
Copper peptides and matrixine-type peptides behave differently and are usually positioned differently, and a formula combining several peptides needs to confirm that they do not compete for the same delivery pathway. Where a brand wants to build a peptide story, the useful discipline is to name the specific peptides and their concentrations on the technical sheet and to be conservative about the claim, rather than to list many peptides at negligible levels.
Bakuchiol: a genuine alternative with a smaller evidence base
Bakuchiol is a plant-derived active that is widely positioned as a gentler alternative to retinol. It is oil-soluble, which means it belongs in an emulsion or an anhydrous base rather than in a water-thin gel, and it is generally well tolerated.
The honest position on evidence is that bakuchiol has published comparative data against retinol, but the body of evidence is much smaller than for retinoids, and a brand that positions it as having equivalent performance is making a claim that needs support. The defensible positioning is gentler, more tolerable and suitable for people who cannot use retinoids, supported by a patch test and a consumer use study.
For a private label brand, bakuchiol is commercially attractive because it permits a retinol-style story without the retinoid exposure, and because it can carry a plant-derived claim. The formulation cost is moderate and the compatibility profile is good.
Delivery, encapsulation and packaging
The delivery system is where an anti-ageing serum is won or lost, because the active with the best data will perform poorly if it has oxidised before the consumer opens the bottle.
Encapsulation serves two purposes: it protects the active during storage and it controls the release rate on skin, which reduces the irritation peak. Encapsulated systems are available for retinoids and for some peptides, and they require the formula to be processed within defined temperature and shear limits, which affects the manufacturing route and the batch record.
Packaging then has to protect what the encapsulation preserved. An airless pump is the standard for a retinol serum because it excludes both light and air and dispenses without drawing contamination back into the reservoir. An opaque bottle with a pump is the next best option. A clear dropper bottle is the worst choice for a retinol product and is still common in the market, which is a reasonable indicator of how much product is sold on presentation rather than on performance.
Where a brand insists on a dropper for the visual language, an amber or opaque glass with a narrow orifice is the compromise, and the stability study should be run in the final pack rather than in a laboratory container so that the real light and air exposure is captured.
How to test for the evidence your claim needs
The testing programme should be built from the claim backwards, and instrumental methods give the most defensible numbers.
Wrinkle appearance is assessed by profilometry or three-dimensional skin imaging, with the result expressed as a change in a defined parameter and compared against a control. Firmness and elasticity are assessed with a cutometer or a comparable instrument. Hydration is measured by corneometry and is the easiest result to obtain, which is why many anti-ageing products lean on it. Skin smoothness and texture are assessed by image analysis or by a trained visual grader.
For any instrumental study, three design details decide whether the result will be accepted: the measurement site, the time of day and the conditions, and the control. Skin measurements vary substantially with temperature, humidity and time since washing, so a study that does not define these cannot be reproduced, and a result that cannot be reproduced is not evidence.
Alongside the instrumental work, a patch test and a consumer use study cover the tolerance and preference claims. Tolerance matters more in this category than in most, because the irritation profile of retinoids is the main reason for returns.
What should an anti-ageing brief contain?
Specify the active family and the intended concentration, whether encapsulation is required, the claim the brand intends to publish, the tolerance profile the brand is targeting, the pack type, the target markets, the first order quantity and the target cost. If a retinol product is planned for more than one market, state the markets explicitly at brief stage, because the permitted concentrations differ and a formula built for the highest limit is not automatically compliant everywhere.
A useful additional discipline is to note which claims will not be made. Deciding explicitly that the brand will not use mechanism language, will not use the word repair, and will not imply a medical effect saves a legal review later and produces a stronger, more credible product story.
Compliance notes for the EU, US and China
In the European Union an anti-ageing serum is a cosmetic under Regulation 1223/2009, requiring a Responsible Person, a Product Information File, a Cosmetic Product Safety Report and CPNP notification. Retinoid restrictions and labelling requirements apply, and claims are assessed against the common criteria in Regulation 655/2013.
In the United States, the Modernization of Cosmetics Regulation Act applies, with facility registration, product listing, safety substantiation and adverse event obligations on the brand or importer. Claims that imply treatment of a condition push the product toward the drug framework, which is a different pathway entirely.
In China, cosmetics are managed under the Cosmetics Supervision and Administration Regulation, where products making a whitening or spot-correcting claim are treated as special cosmetics requiring registration rather than filing. Anti-wrinkle claims are subject to the cosmetic efficacy claim requirements, which means the evidence has to be assembled before the claim is published.
Frequently asked questions about anti-ageing serum OEM
What is the minimum order quantity?
For a serum in a stock airless pack, MOQ is driven mainly by the pack and the filling run. Where encapsulation is used, the encapsulate supplier may impose its own minimum batch, which can raise the threshold.
Can you combine retinol and peptides in one serum?
It is possible but it is a compromise. Combining them usually means reducing the retinol concentration to keep the formula tolerable, so a brand often gets better commercial results from two separate products than from one combined hero serum.
Can you match an anti-ageing serum we already sell?
We can benchmark an existing product and develop a formula to the same brief. We do not copy a third party formula, and we ask brands to confirm they hold the rights to any formula they ask us to reproduce.
How long does development take?
A first sample typically takes two to three weeks after the brief is frozen, with two or three rounds common. Encapsulated systems and stability work add time, and instrumental claim testing should be scheduled alongside the stability programme rather than after it.
Do you supply the reports needed for filing and claims?
Yes. Stability, pack compatibility, microbiological challenge and safety documentation are produced for every project, and we can arrange the instrumental and panel testing that supports an appearance-based claim.
Next step: send us your anti-ageing brief
Tell us the active route you want to take, the claim you intend to make, the tolerance profile you are targeting and your markets, and we will propose a formulation, a delivery system, packaging options and a costed quote. Write to capsulebiotech@163.com, message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319, or use the inquiry form and we will reply within one working day.
Related programmes and guides: anti-wrinkle firming facial essence, blue copper peptide repair serum, and firming face cream.